Redx Pharma
R&D update: RXC004 and RXC007 in the spotlightRedx Pharma
ESMO 2021: RXC004 monotherapy Phase I study resultsRedx Pharma
Kadmon acquisition has read across for RXC007Redx Pharma
All that Jazz: $3m milestone boosts cash and confidenceRedx Pharma
RXC004 2mg dose selected for Phase II trialsRedx Pharma
Rezurock approval has positive read across for RedxRedx Pharma
Receipt of $4m milestone for RXC006 progressRedx Pharma
Momentum and execution continue in H121Redx Pharma
FY20 results highlight extent of progress madeRedx Pharma
Funding secured to support next chapter of growth